{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20213169,Language='FR')/Transcripts"}},"ID":20213169,"Language":"FR","BusinessShortNumber":"21.3169","BusinessType":8,"BusinessTypeName":"Interpellation","BusinessTypeAbbreviation":"Ip.","Title":"Fiasco de l'achat de vaccin anti-Covid-19 (4). Pr\u00e9f\u00e9rence donn\u00e9e \u00e0 Moderna pour l'achat du vaccin?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Selon la r\u00e9ponse que le Conseil f\u00e9d\u00e9ral a donn\u00e9e aux questions no 21.7365, 21.7366, 21.7367, 21.7368, 21.7369 et 21.7370 de l'heure des questions, les achats de vaccin ont \u00e9t\u00e9 discut\u00e9s et d\u00e9cid\u00e9s par l'ensemble du Conseil f\u00e9d\u00e9ral. Le d\u00e9lai serr\u00e9 l'ayant manifestement emp\u00each\u00e9 de r\u00e9pondre \u00e0 la question no 21.7368 pendant la session printemps, je le prie de le faire en vue de la session d'\u00e9t\u00e9 2021.</p><p>- Est-il exact que le Conseil f\u00e9d\u00e9ral a mis\u00e9 unilat\u00e9ralement sur le vaccin Moderna produit en Valais par Lonza, au lieu de prospecter plus largement, et qu'il porte ainsi la responsabilit\u00e9 de la lenteur de la vaccination en Suisse et de la prolongation du confinement\u00a0?</p><p>- Quel organe a nomm\u00e9 Nora Kronig Romero, chef de la division Affaires internationales de l'OFSP, au poste de responsable des achats de vaccin anti-COVID-19\u00a0?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":"<p>La Conf\u00e9d\u00e9ration a mis en oeuvre une strat\u00e9gie d'approvisionnement diversifi\u00e9e et sign\u00e9 des contrats avec plusieurs entreprises, le but \u00e9tant de r\u00e9duire le risque li\u00e9 \u00e0 l'\u00e9chec de chaque vaccin candidat ou de plateformes technologiques enti\u00e8res. Elle a conclu des contrats avec Pfizer/BioNTech, Moderna, CureVac, AstraZeneca et Novavax. La Conf\u00e9d\u00e9ration est aussi en n\u00e9gociation avec d'autres entreprises afin d'adapter le portefeuille de vaccins \u00e0 l'\u00e9volution de la pand\u00e9mie. Par ailleurs, la Suisse participe \u00e0 l'initiative COVAX, qui lui permet de prendre part \u00e0 un m\u00e9canisme d'achat multilat\u00e9ral.</p><p>En f\u00e9vrier 2020, la taskforce de l'Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP) a d\u00e9cid\u00e9 de mettre sur pied un groupe de travail Vaccins. En raison l'orientation internationale des travaux, les t\u00e2ches du groupe de travail Vaccins ont \u00e9t\u00e9 confi\u00e9es \u00e0 la responsable de la division Affaires internationales.</p>  R\u00e9ponse du Conseil f\u00e9d\u00e9ral.","FederalCouncilProposal":8,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":"\/Date(1621987200000)\/","SubmittedBy":"Aeschi Thomas","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1679011200000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"D\u00e9partement de l'int\u00e9rieur","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"4|2841","Category":null,"Modified":"\/Date(1712764245257)\/","SubmissionDate":"\/Date(1615766400000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5108,"SubmissionLegislativePeriod":51,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Politique d'Etat|Sant\u00e9"}}